BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38412093)

  • 1. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
    Zeng PYF; Prokopec SD; Lai SY; Pinto N; Chan-Seng-Yue MA; Clifton-Bligh R; Williams MD; Howlett CJ; Plantinga P; Cecchini MJ; Lam AK; Siddiqui I; Wang J; Sun RX; Watson JD; Korah R; Carling T; Agrawal N; Cipriani N; Ball D; Nelkin B; Rooper LM; Bishop JA; Garnis C; Berean K; Nicolson NG; Weinberger P; Henderson YC; Lalansingh CM; Tian M; Yamaguchi TN; Livingstone J; Salcedo A; Patel K; Vizeacoumar F; Datti A; Xi L; Nikiforov YE; Smallridge R; Copland JA; Marlow LA; Hyrcza MD; Delbridge L; Sidhu S; Sywak M; Robinson B; Fung K; Ghasemi F; Kwan K; MacNeil SD; Mendez A; Palma DA; Khan MI; Shaikh M; Ruicci KM; Wehrli B; Winquist E; Yoo J; Mymryk JS; Rocco JW; Wheeler D; Scherer S; Giordano TJ; Barrett JW; Faquin WC; Gill AJ; Clayman G; Boutros PC; Nichols AC
    Cell Rep; 2024 Mar; 43(3):113826. PubMed ID: 38412093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
    Nikiforov YE
    Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestor.
    Dong W; Nicolson NG; Choi J; Barbieri AL; Kunstman JW; Abou Azar S; Knight J; Bilguvar K; Mane SM; Lifton RP; Korah R; Carling T
    Genes Chromosomes Cancer; 2018 Dec; 57(12):645-652. PubMed ID: 30136351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.
    Begum S; Rosenbaum E; Henrique R; Cohen Y; Sidransky D; Westra WH
    Mod Pathol; 2004 Nov; 17(11):1359-63. PubMed ID: 15195111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer.
    Mika J; Łabaj W; Chekan M; Abramowicz A; Pietrowska M; Polański A; Widłak P
    J Appl Genet; 2021 Feb; 62(1):115-120. PubMed ID: 33222100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study.
    Kuhn E; Ragazzi M; Ciarrocchi A; Torricelli F; de Biase D; Zanetti E; Bisagni A; Corrado S; Uccella S; La Rosa S; Bongiovanni M; Losito S; Piana S
    Mod Pathol; 2019 Jun; 32(6):787-798. PubMed ID: 30723294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?
    Juhlin CC
    Cancer Drug Resist; 2020; 3(4):992-1000. PubMed ID: 35582231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
    Cracolici V; Cipriani NA
    Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
    Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
    Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
    Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.
    Paulsson JO; Backman S; Wang N; Stenman A; Crona J; Thutkawkorapin J; Ghaderi M; Tham E; Stålberg P; Zedenius J; Juhlin CC
    J Pathol; 2020 Feb; 250(2):183-194. PubMed ID: 31621921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
    Volante M; Lam AK; Papotti M; Tallini G
    Endocr Pathol; 2021 Mar; 32(1):63-76. PubMed ID: 33543394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of well-differentiated thyroid carcinoma with insular or anaplastic thyroid carcinoma; evidence for dedifferentiation in tumor progression.
    Van der Laan BFAM; Freeman JL; Tsanq RW; Asa SL
    Endocr Pathol; 1993 Dec; 4(4):215-221. PubMed ID: 32370456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
    Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
    Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.
    Nakamura T; Yana I; Kobayashi T; Shin E; Karakawa K; Fujita S; Miya A; Mori T; Nishisho I; Takai S
    Jpn J Cancer Res; 1992 Dec; 83(12):1293-8. PubMed ID: 1483945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
    Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
    Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
    Landa I; Ibrahimpasic T; Boucai L; Sinha R; Knauf JA; Shah RH; Dogan S; Ricarte-Filho JC; Krishnamoorthy GP; Xu B; Schultz N; Berger MF; Sander C; Taylor BS; Ghossein R; Ganly I; Fagin JA
    J Clin Invest; 2016 Mar; 126(3):1052-66. PubMed ID: 26878173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
    Kasaian K; Wiseman SM; Walker BA; Schein JE; Zhao Y; Hirst M; Moore RA; Mungall AJ; Marra MA; Jones SJ
    BMC Cancer; 2015 Dec; 15():984. PubMed ID: 26680454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
    Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
    Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.